TrialCancer medicine2020

A phase 2 study of GVAX colon vaccine with cyclophosphamide and pembrolizumab in patients with mismatch repair proficient advanced colorectal cancer.

Mark Yarchoan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.